Despite all the care given to this publication of the patient information leaflets and the SPC of the authorized medicines in Belgium, the FAMHP cannot guarantee the completeness and the conformity with the approved data in the context of clinical trials in Belgium.

Don't hesitate to send your remarks or comments to ct.rd@fagg.be.

The FAMHP declines all liability for any direct or indirect damage resulting from the use of this database. The FAMHP also reminds readers that this information in no way replaces the advice of your doctor or pharmacist for any use of a medicine.

The information published on this website is absolutely no indication of the availability of a medicinal product on the market, particularly in the sense of art. 72a, § 1bis of the Act on compulsory insurance for medical care and benefits, coordinated on 14 July 1994.

The FAMHP gives no guarantee that the information included in this database follows the right of the intellectual property.